MEDANTA Q2FY27 : CONS NET PROFIT UP 38.3% AT ₹219.1 CR (YOY), UP 39.3% (QOQ). STRONG (On 1st Look)

Revenue up 33.6% at ₹1,469.0 Cr (YOY), up 12.6% (QOQ). Ebitda up 60.2% at ₹370.1 Cr (YOY); margins 25.2% v 21.0% (YOY), 22.0% (QOQ). Caution: Q2FY26 PBT included ₹16 Cr exceptional income from stamp duty reversal.

Global Health Ltd

Open attachment

← Back to feed